Search by Drug Name or NDC
NDC 00006-4293-02 ERVEBO 72000000 [PFU]/mL Details
ERVEBO 72000000 [PFU]/mL
ERVEBO is a INTRAMUSCULAR INJECTION, SOLUTION in the VACCINE category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN.
Product Information
| NDC | 00006-4293 |
|---|---|
| Product ID | 0006-4293_14d5a05f-f95b-4fa5-af7e-db027a00a128 |
| Associated GPIs | |
| GCN Sequence Number | 080594 |
| GCN Sequence Number Description | ebola (Zaire)vacc,live,vero/PF VIAL 1 ML INTRAMUSC |
| HIC3 | W7B |
| HIC3 Description | VIRAL/TUMORIGENIC VACCINES |
| GCN | 47487 |
| HICL Sequence Number | 046278 |
| HICL Sequence Number Description | EBOLA (ZAIRE) RECOMBINANT VACCINE, LIVE, VERO CELL/PF |
| Brand/Generic | Brand |
| Proprietary Name | ERVEBO |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN |
| Product Type | VACCINE |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR |
| Active Ingredient Strength | 72000000 |
| Active Ingredient Units | [PFU]/mL |
| Substance Name | ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN |
| Labeler Name | Merck Sharp & Dohme LLC |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA125690 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00006-4293-02 (00006429302)
| NDC Package Code | 0006-4293-02 |
|---|---|
| Billing NDC | 00006429302 |
| Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4293-02) / 1 mL in 1 VIAL, SINGLE-DOSE (0006-4293-01) |
| Marketing Start Date | 2019-12-19 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |